Cas:22895-19-8 dimethyl 4-methoxybenzene-1,2-dicarboxylate manufacturer & supplier

Chemical Name:dimethyl 4-methoxybenzene-1,2-dicarboxylate

CAS.NO:22895-19-8

Synonyms:MFCD00077817;Dimethyl 4-methoxyphthalate;4-methoxy-phthalic acid dimethyl ester;4-Methoxy-phthalsaeure-dimethylester;4-Methoxyphthalsaeure-methylester;dimethyl-4-methoxyphtalate

Molecular Formula:C₁₁H₁₂O₅

Molecular Weight:224.21000

HS Code:2918990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:140ºC0.1 mm Hg(lit.)

Density:1.225 g/mL at 20ºC(lit.)

Index of Refraction:n20/D 1.531

PSA:61.83000

Exact Mass:224.06800

LogP:1.26840

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like MFCD00077817 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dimethyl-4-methoxyphtalate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Methoxy-phthalsaeure-dimethylester Use and application,4-methoxy-phthalic acid dimethyl ester technical grade,usp/ep/jp grade.

Related News: The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy. dimethyl 4-methoxybenzene-1,2-dicarboxylate manufacturer Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. dimethyl 4-methoxybenzene-1,2-dicarboxylate supplier The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. dimethyl 4-methoxybenzene-1,2-dicarboxylate vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. dimethyl 4-methoxybenzene-1,2-dicarboxylate factory The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.